It is with great honor that we introduce Dr. Serge Rousselle as StageBio’s Chief Scientific Officer. Dr. Rousselle is the co-founder of Alizee Pathology (now part of StageBio) a world-renowned veterinary pathologist with special interest in digital pathology and image analysis.
The StageBio team is looking forward to attending the 2021 Society of Toxicology’s Annual Meeting and ToxExpo this month - and we hope to see you there!
Dr. Deepa Rao, Veterinary Toxicologic Pathologist at StageBio, has been elected Councilor on the Executive Committee of the Society of Toxicologic Pathology.
StageBio Virtual Necropsy & Courier/Archiving Solutions Reduce Timelines!
StageBio expands its global presence with acquisition of TPL Path Labs
StageBio Announces Opening of New Facility in Greater Boston Area
At this time our production schedule is on track, with no unplanned delays.
The orthopedic device sector of the medical device industry is fast-growing and constantly evolving. Histopathological evaluation of orthopedic devices provides a critical assessment for determining the safety and efficacy of these next-generation biomaterials, especially with continued advancements in technology and designs of orthopedic devices. Proper evaluation of the biocompatibility of orthopedic implants should include advanced histological imaging and processing techniques to better assess tissue response surrounding the implant and to gauge the potential for adverse effects. This is the seventh and final article in this series where we highlight a portion of the article published by Nicolette Jackson et al. discussing the different types of mechanical testing used during the evaluation of orthopedic devices in preclinical animal studies.
513.204.4400
